Patent Issued for Parasiticidal collar comprising isoxazoline compounds (USPTO 12161089).

Boehringer Ingelheim Animal Health USA Inc. has been issued a patent for a parasiticidal collar containing isoxazoline compounds for the treatment and prevention of parasite infections in animals. The collar may also include tigolaner, a compound with acaracidal and insecticidal properties. The patent describes the composition of the collar, which includes a polymer matrix with isoxazoline active agents and optional additives like plasticizers and stabilizers. This invention aims to provide a long-acting solution for controlling parasite infestations in domesticated animals like cats and dogs. [Extracted from the article]